Literature DB >> 34823737

Tobacco Use Disorder.

Frank T Leone1, Sarah Evers-Casey2.   

Abstract

Tobacco use disorder is highly prevalent; more than a billion individuals use tobacco worldwide. Popular views on the addictive potential of tobacco often underestimate the complex neural adaptations that underpin continued use. Although sometimes trivialized as a minor substance, effects of nicotine on behavior lead to profound morbidity over a lifetime of exposure. Innovations in processing have led to potent forms of tobacco and delivery devices. Proactive treatment strategies focus on pharmacotherapeutic interventions. Innovations on the horizon hold promise to help clinicians address this problem in a phenotypically tailored manner. Efforts are needed to prevent tobacco use for future generations.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nicotine; Pharmacotherapeutic interventions; Smoking treatment; Tobacco use

Mesh:

Substances:

Year:  2022        PMID: 34823737      PMCID: PMC8630801          DOI: 10.1016/j.mcna.2021.08.011

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  83 in total

1.  Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.

Authors:  Peter Hajek; Hayden J McRobbie; Katie E Myers; John Stapleton; Al-Rehan Dhanji
Journal:  Arch Intern Med       Date:  2011-04-25

2.  Inattention as a key predictor of tobacco use in adolescence.

Authors:  Jeffrey D Burke; Rolf Loeber; Helene Raskin White; Magda Stouthamer-Loeber; Dustin A Pardini
Journal:  J Abnorm Psychol       Date:  2007-05

Review 3.  Bupropion: a review of its use in the management of smoking cessation.

Authors:  K J Holm; C M Spencer
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area.

Authors:  Satoshi Ikemoto; Mei Qin; Zhong-Hua Liu
Journal:  J Neurosci       Date:  2006-01-18       Impact factor: 6.167

5.  An association of CYP2A6 genotype and smoking topography.

Authors:  Andrew A Strasser; Viba Malaiyandi; Ewa Hoffmann; Rachel F Tyndale; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2007-04       Impact factor: 4.244

6.  Undertreatment of tobacco use relative to other chronic conditions.

Authors:  Steven L Bernstein; Sunkyung Yu; Lori A Post; James Dziura; Nancy A Rigotti
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

7.  Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

Authors:  W A Corrigall; K M Coen; K L Adamson
Journal:  Brain Res       Date:  1994-08-08       Impact factor: 3.252

8.  Characterization of Nicotine Salts in 23 Electronic Cigarette Refill Liquids.

Authors:  Arit M Harvanko; Christopher M Havel; Peyton Jacob; Neal L Benowitz
Journal:  Nicotine Tob Res       Date:  2020-06-12       Impact factor: 4.244

Review 9.  Is e-cigarette use in non-smoking young adults associated with later smoking? A systematic review and meta-analysis.

Authors:  Jasmine N Khouja; Steph F Suddell; Sarah E Peters; Amy E Taylor; Marcus R Munafò
Journal:  Tob Control       Date:  2020-03-10       Impact factor: 7.552

Review 10.  Modeling brain, symptom, and behavior in the winds of change.

Authors:  David M Lydon-Staley; Eli J Cornblath; Ann Sizemore Blevins; Danielle S Bassett
Journal:  Neuropsychopharmacology       Date:  2020-08-28       Impact factor: 8.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.